🇺🇸 FDA
Patent

US 7553936

Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions

granted A61PA61P29/00A61P31/04

Quick answer

US patent 7553936 (Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions) held by UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Grant date
Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P29/00, A61P31/04, A61P35/00, A61P9/00